InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: Pctwst post# 152075

Tuesday, 03/09/2021 11:36:48 PM

Tuesday, March 09, 2021 11:36:48 PM

Post# of 232871
CD12 was absolutely the best trial for any medication in Covid19 yet. It was designed at the start before anyone knew much about Covid19 and before they knew how to apply Leronlimab to Covid19. It was really a Phase 2/3 exploratory trial that could have by luck gotten approval. All other trials failed completely Leronlimab now has a clear path to approval. Rarely ever do any first Phase 3s even for BP lead to approval when the first Phase 3 is a new indication. The ones that do are already approved drugs and the trial is for a new indication or label expansion.
Leronlimab now is more valuable because even though not approved yet it has another successful trial and a much larger body of knowledge and evidence and experience with extremely fragile patients. Think of it like undeveloped real estate in a prime commercial location. The value and income will not be derived until it is developed and the office tower or shopping center is built. The undeveloped lots are extremely valuable unique and irreplaceable. No one else has it. But there is no income yet. The plans must be drawn up and certified by engineers and architects ( clinical trials) then the zoning and building permits has to be issued by the legal authorities based on those detailed engineering studies and environmental impact statements. (FDA or other Reg Approval) What is the highest and best use of this valuable undeveloped real estate (drug)? HIV or Cancer? What can be built or a corner of the lot to help fund the rest of the development? Acute Covid, Long Haulers, and Post Viral Syndrome?
CytoDyn does not have a problem with the real estate (drug) it is a fantastic well-positioned valuable lot.
CytoDyn does not have a problem with the engineering or architectural plans. The clinical trials have been great so far they just need some minor revisions.
CytoDyn does have a funding problem. They need to concentrate on that one little corner development for the Covid related indications to get cash flow to fund the building of the CytoDyn version of the Petronas Twin Towers. (Built according to the Islamic Architectural Tradition to reflect on the glory of God even though a commercial building). Twin towers of Cancer and Nash paid for by Covid cash flow is the vision and it is a brilliant one.
CD16 is a clear path to realize this vision of cash flow. It is readily achievable and we have the right Architect in Dr. Mahboob U. Rahman M.D., Ph.D., FACR
May God help them achieve this daring vision for the betterment of all mankind.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News